New And Special Drugs

Anxu (Rovadicitinib) – Myelofibrosis | HongKong DengYue Medicine

Goxblem (Bemiltenase alfa) – Hemophilia A/B | HongKong DengYue Medicine

Kardorisso (Asandeutertinib) – NSCLC | HongKong DengYue Medicine

Atled (Fanregratinib) – Intrahepatic Cholangiocarcinoma | HongKong DengYue Medicine

Redemplo (Plozasiran) – FCS | HongKong DengYue Medicine

Yizekang (Izalontamab Brengitecan) – NPC/ESCC | HongKong DengYue Medicine

Qiyoukang (Gumokimab) – Plaque Psoriasis | HongKong DengYue Medicine

Lukeda (Rocbrutinib) – MCL | HongKong DengYue Medicine
What Can We Offer You?

Generic drugs
Dedicated to providing high-quality, affordable medicines around the world

Vitamins and Supplements
A balanced diet by addressing different deficiencies with the right dosage

brand name medicines
DengYue Medicine as China Drug Import and Export Wholesaler, fills the gap between quality and quantity by adding some affordability

Fast-moving consumer goods
Stock a full range of products from sanitary napkins to foot care creams for your daily needs

non-prescription drugs
Flagship OTC brand - approved and accepted by global standards

Medical supplies and auxiliary supplies
Explore continually updated supplies, diagnostic equipment and essential tools
News
HongKong DengYue Medicine Wholesaler focus on medical trends and obtain new drug directions.

Latest Innovative Drug Approvals in China 2026
This article highlights the latest innovative drug approvals in China 2026, covering drug names, indications, pharmaceutical companies, and approval dates across multiple therapeutic areas. It

Bayer’s Asundexian Approved in China: A Novel FXIa Inhibitor for Stroke Prevention
On October 26, 2026, China’s NMPA approved Bayer’s novel coagulation factor XIa (FXIa) inhibitor, asundexian, to reduce stroke risk in adults following a non-cardioembolic ischemic

China Rare Disease Drug Catalog: Drug List, Indications, and Approval Information
The China rare disease drug catalog provides an overview of rare disease medicines, including their indications, manufacturers, and approval dates. Rare diseases affect relatively small

New Drug Batoclimab for Myasthenia Gravis Approved in China, Advancing FcRn-Targeted Therapy
On October 22, 2026, China’s NMPA official website showed the approval of batoclimab injection for adults with AChR antibody-positive generalized myasthenia gravis (gMG), in combination

How to Choose Oral Nutritional Supplements for Cancer Patients: Types, Protein Needs & Usage Guide
Malnutrition is a common concern among people with cancer. It may be associated with reduced appetite, adverse effects of anticancer treatment, and disease-related metabolic changes,

Targeted Drugs for Thyroid Cancer by Cancer Type: Common Agents and Molecular Targets
Key Takeaways Thyroid cancer is a common endocrine malignancy. For some patients with advanced, metastatic or progressive disease, targeted therapy provides important treatment options. Hong

What Are Taxane Anticancer Drugs? 5 Common Types, Uses, and Differences
Key Takeaways Taxane chemotherapy drugs are an important component of solid tumor treatment and are widely used in the management of cancers such as breast

Chinese Cancer Drugs Are Gaining Global Influence
Key Takeaways From a pharmaceutical industry once focused largely on generic medicines and imported drugs to one producing an expanding pipeline of domestically developed cancer
Fast And Safe Delivery

Global Transportation Express

Temperature-controlled Transport

Safe Transportation, GDP Compliant









